K-numberK251238
Device nameVasoview Hemopro 3 Endoscopic Vessel Harvesting System (VH-6000); Vasoview Hemopro 3 Endoscopic Vessel Harvesting System with Vasoshield (VH-6001); Vasoview Hemopro 3 Power Supply (VH-6010)
ApplicantMaquet Cardiovascular, LLC
Product codeGEI
Device classClass II
Decision dateMay 30, 2025
DecisionSubstantially Equivalent
Regulation878.4400
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Vasoview Hemopro 3 is an endoscopic vessel harvesting system for minimally invasive surgery, primarily used in coronary and peripheral artery bypass procedures. It cuts tissue and controls bleeding through heat-based coagulation using direct current heating elements in curved jaws, and enables blunt dissection of blood vessels, ducts, and surrounding structures under endoscopic visualization.

Technological characteristics

The device has the same intended use, operating principles, basic design, sterilization method, and sterile packaging as predicate devices. The only modification is a material change to the C-Ring component of the harvesting cannula. Both jaw designs include insulation protecting adjacent tissue, with three heating elements (two for cauterization, one for cutting) powered by direct current only, not radiofrequency.

Test standards cited

Bench testing used ANSI/AAMI ES60601-1, ANSI/AAMI HE75, IEC 60601-1-2, IEC 60601-1-6, ISO 15223-1, ISO 20417, ISO 14971, ISO 17664-2, ISO 11137-3, and ASTM D4169-22. No clinical testing was conducted.

Substantial equivalence argument

The C-Ring material change does not affect the device's core function because design verification and validation testing—including mechanical/thermal characterization, durability, and extreme-use cadaver testing—demonstrated that the modified component maintains equivalent performance. Since the modification raises no new safety or effectiveness questions and all other technological characteristics remain identical to the predicate, substantial equivalence is established.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →